Release Profile of Salofalk 750 mg Tablets
This study determined the release profile of Salofalk 750 mg tablets (Axcan Pharma), an enteric-coated 5-aminosalicylic acid (5-ASA) preparation. Twenty-one ileostomates were divided into two groups and studied. Group 1 consisted of 10 subjects (five males, five females, mean age 39 years) who had a...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Hindawi Limited
1995-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/1995/513718 |